Contract Notice Detail

Summary Information


Base Total Price:	40,800.000000 Euro
Request Reference:	10E0850723
Request Name:	Aquisição de INFLIXIMAB BIOSSIMILAR CELLTRION IV 100 ao Laboratorio Pharmakern para o HFF para o ano de 2023
Phase:	Tendering Phase
State:	Awarded
Description:	Aquisição de INFLIXIMAB BIOSSIMILAR CELLTRION IV 100 ao Laboratorio Pharmakern para o HFF para o ano de 2023
Procedure Type:	VortalGOV - Direct Award (ECP)

Object of the Contract

Type of Contract:

Supplies Acquisition

Main Object CPV Main Category:

Ic19 Amadora 2700 Venteira Amadora Lisboa PORTUGAL

CPV Main Vocabulary

33600000-6 - Pharmaceutical products

CPV Supplementary Vocabulary

Additional Classifications List

Scheduling

Request online publishing date:	10/6/2023 10:17 AM (UTC +1 hour)
Due datetime for receiving replies:	10/9/2023 5:00 PM (UTC +1 hour)

Financial Settings

Define Warranties?

Contract Documents

Document Name	Description
Convite_10E0850723.pdf	Convite_10E0850723.pdf	Download
solicitaçãocotação.xlsx	solicitaçãocotação.xlsx	Download
Caderno Encargos_10E0850723.pdf	Caderno Encargos_10E0850723.pdf	Download

Object of contract

This contract is subject to renewal?	No
The procurement is related to a project and/or programme financed by European Union funds?	No

Legal, economic, financial and technical information

The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?

Questionnaire

Vision

Secção

1.1

Articulado da Consulta

CódigoDescrição QtUnidade

INFLIXIMAB BIOSSIMILAR CELLTRION IV 100

600,000000

Totais(Os valores mostrados não incluem IVA)

Evaluation